Alignment Healthcare Inc (NASDAQ:ALHC)’s traded shares stood at 6.92 million during the last session, with the company’s beta value hitting 1.45. At the last check today, the stock’s price was $11.10, to imply a decrease of -13.52% or -$1.73 in intraday trading. The ALHC share’s 52-week high remains $14.25, putting it -28.38% down since that peak but still an impressive 59.82% since price per share fell to its 52-week low of $4.46. The company has a valuation of $2.13B, with an average of 1.36 million shares in intraday trading volume over the past 10 days and average of 1.31 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Alignment Healthcare Inc (ALHC), translating to a mean rating of 2.00. Of 10 analyst(s) looking at the stock, 0 analyst(s) give ALHC a Sell rating. 1 of those analysts rate the stock as Overweight while 3 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Alignment Healthcare Inc (NASDAQ:ALHC) trade information
After registering a -13.52% downside in the latest session, Alignment Healthcare Inc (ALHC) has traded red over the past five days. The 5-day price performance for the stock is -18.84%, and -2.93% over 30 days. With these gigs, the year-to-date price performance is 28.86%. Short interest in Alignment Healthcare Inc (NASDAQ:ALHC) saw shorts transact 4.51 million shares and set a 2.77 days time to cover.
The extremes give us $7 and $12 for target low and target high price respectively. As such, ALHC has been trading -8.11% off suggested target high and 36.94% from its likely low.
Alignment Healthcare Inc (ALHC) estimates and forecasts
Looking at statistics comparing Alignment Healthcare Inc share performance against respective industry, we note that the company has outperformed competitors. Alignment Healthcare Inc (ALHC) shares are 52.82% up over the last 6 months, with its year-to-date growth rate higher than industry average at 12.66% against 5.70%. Revenue is forecast to grow 31.25% this quarter before falling -45.16% for the next one. The rating firms project that company’s revenue will grow 46.81% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is 675.47M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 846.8M.Earnings reports from the last fiscal year show that sales brought in 465.39M and 628.6M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 45.14% before jumping 34.71% in the following quarter.
ALHC Dividends
Alignment Healthcare Inc has its next earnings report out on 2025-Feb-25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Alignment Healthcare Inc (NASDAQ:ALHC)’s Major holders
Alignment Healthcare Inc insiders hold 5.21% of total outstanding shares, with institutional holders owning 87.23% of the shares at 92.03% float percentage. In total, 87.23% institutions holds shares in the company, led by GENERAL ATLANTIC, L.P.. As of 2024-06-30, the company held over 60.99 million shares (or 32.2707% of shares), all amounting to roughly $476.97 million.
The next major institution holding the largest number of shares is WARBURG PINCUS LLC with 17.92 million shares, or about 9.4827% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $140.16 million.
